AZACITIDINE (Shilpa Medicare Limited)
Welcome to the PulseAid listing for the AZACITIDINE drug offered from Shilpa Medicare Limited. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Shilpa Medicare Limited |
NON-PROPRIETARY NAME: | azacitidine for |
SUBSTANCE NAME: | AZACITIDINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
ROUTE: | INTRAVENOUS; SUBCUTANEOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-12-05 |
END MARKETING DATE: | 0000-00-00 |
AZACITIDINE HUMAN PRESCRIPTION DRUG Details:
Item Description | AZACITIDINE from Shilpa Medicare Limited |
LABELER NAME: | Shilpa Medicare Limited |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(mg/1) |
START MARKETING DATE: | 2016-12-05 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 63759-0003_aa9df125-bf25-4ac9-a339-a0e6638be29c |
PRODUCT NDC: | 63759-0003 |
APPLICATION NUMBER: | ANDA207518 |
Other AZACITIDINE Pharmaceutical Manufacturers / Labelers: